Christopher Bowden
2016
Compensation breakdown
Non-Equity Incentive Plan | $174,440 |
---|---|
Option Awards | $1,145,987 |
Salary | $436,091 |
Other | $9,103 |
Total | $1,765,621 |
Bowden received $1.1M in option awards, accounting for 65% of the total pay in 2016.
Bowden also received $174.4K in non-equity incentive plan, $436.1K in salary and $9.1K in other compensation.
Rankings
In 2016, Christopher Bowden's compensation ranked 5,467th out of 14,075 executives tracked by ExecPay. In other words, Bowden earned more than 61.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,467 | 61st |
Manufacturing | 1,959 | 64th |
Chemicals And Allied Products | 620 | 67th |
Drugs | 463 | 70th |
Pharmaceutical Preparations | 368 | 69th |
Bowden's colleagues
We found five more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2016.
2016
Andrew Hirsch
Agios Pharmaceuticals
Chief Financial Officer
2016
Steve Hoerter
Agios Pharmaceuticals
Chief Commercial Officer
2016
David Schenkein
Agios Pharmaceuticals
Chief Executive Officer
2016
Scott Biller
Agios Pharmaceuticals
Chief Scientific Officer
2016
Glenn Goddard
Agios Pharmaceuticals
Former Sr. Vice President, Finance
News
April 28, 2022
April 8, 2021
April 16, 2020
April 18, 2019